|
Neutrophil encapsulation platform for targeted drug delivery |
Allen, Christine |
Targeted Drug Delivery |
University of Toronto |
|
Development of the Metaplex immuno-oncology platform
|
Bally, Marcel |
Targeted Drug Delivery |
UBC |
|
Triggered release of anticancer drugs from lipid nanoparticles
|
Cullis, Pieter |
Targeted Drug Delivery |
UBC |
|
Nanoparticle formulations for anti-inflammatory IDR peptides
|
Hancock, Robert |
Targeted Drug Delivery |
UBC |
|
Nano-delivery of novel inhibitors of DNA repair for enhanced therapy in head & neck cancer
|
Lavasanifar, Afsaneh |
Targeted Drug Delivery |
University of Alberta |
|
Targeting myeloid leukemia with nanomedicines
|
Rossi, Fabio |
Targeted Drug Delivery |
UBC |
|
Targeting the NLRP3 inflammasome with lipid nanoparticles for the treatment of type 2 diabetes
|
Verchere, Bruce |
Targeted Drug Delivery |
UBC |
|
Lipidic nanoparticle formulation of a triple adjuvant for intranasal vaccines
|
Wasan, Ellen |
Targeted Drug Delivery |
University of Saskatchewan |
|
Development of an aerosolized liposomal hydroxychloroquine for treating COVID-19 patients entering hospitals
|
Bally, Marcel |
Targeted Drug Delivery |
UBC |
|
Development of a targeted FAST-LNP formulation of cabazitaxel to improve efficacy and safety for prostate cancer treatment
|
Lewis, John |
Targeted Drug Delivery |
University of Alberta |
|
Lipid Nanoparticle-mediated Immunotherapy for Pseudomyxoma Peritonei
|
Li, Shyh-Dar |
Targeted Drug Delivery |
UBC |
|
GeneCure: Application of lipid nanoparticle technology to gene therapies in a variety of tissues
|
Cullis, Pieter |
Gene Therapy |
UBC |
|
A multiomics screen to identify phagocyte-specific LNPs for immunotherapy
|
Harder, Kenneth |
Gene Therapy |
UBC |
|
Development and optimization of LNP-based gene therapy approaches in the brain
|
Leavitt, Blair |
Gene Therapy |
UBC |
|
Site-specific laser-mediated gene therapy for corneal endothelial diseases
|
Meunier, Michel |
Gene Therapy |
Polytechnique Montreal |
|
Development and utilization of in vivo systems to optimize lipid nanoparticles for therapeutic genome editing: Focus on delivery to muscle for the treatment of LPL Deficiency
|
Ross, Colin |
Gene Therapy |
UBC |
|
COVID-19 Therapeutics
|
Cullis, Pieter |
Gene Therapy |
UBC |
|
Synthesis and Evaluation of Novel Sulfur-Containing Lipids
|
Ciufolini, Marco |
Gene Therapy |
UBC |
|
Developing a Long-Acting Prophylactic Treatment for Hemophilia using siRNA-Mediated Inhibition of Fibrinolysis
|
Kastrup, Christian |
Gene Therapy |
UBC |
|
Predicting nanoparticle tumour delivery via serum protein adsorption
|
Chan, Warren |
Diagnostics |
University of Toronto |
|
Development of an integrated chip for exosome analysis in cancer
|
Kelley, Shana |
Diagnostics |
University of Toronto |
|
On-Demand biofunctionalization of lipid nanoparticles for CAR T Cell Therapy
|
Pardee, Keith |
Diagnostics |
University of Toronto |
|
A platform to screen for upregulation of soluble calreticulin as a tool to develop nanomedicines targeting acute myeloid leukemia
|
Walker, Gilbert |
Diagnostics |
University of Toronto |
|
Customisable metallo-nanotexaphyrins for cancer imaging and therapy
|
Zheng, Gang |
Diagnostics |
University of Toronto |
|
NMIN Theme 3: Research & KTEE Accelerator Project
|
Kelley, Shana |
Diagnostics |
University of Toronto |
|
An ultrasensitive digital nanoassay for immunotherapy effectiveness
|
Wheeler, Aaron |
Diagnostics |
University of Toronto |
|
Nanoparticle-enhanced, impedance-based biosensor development for cancer diagnostics
|
Wishart, David |
Diagnostics |
University of Alberta |
|
PharmaCore: Preclinical Scale-up Manufacturing & Project Management Core Facility
|
Bally, Marcel |
Core Facilities |
UBC |
|
NanoCore: The Translational NanoMedicines Formulation & Characterization Core Facility
|
Cullis, Pieter |
Core Facilities |
UBC |